CION 8-K

CION Investment Corp (CION)

8-K 2025-12-18 For: 2025-12-16

Added on April 11, 2026

Maryland		814-00941		45-3058280
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common stock, par value $0.001 per share	CION	The New York Stock Exchange
7.50% Notes due 2029	CICB	The New York Stock Exchange

10.1	Note Purchase Agreement, dated as of December 16, 2025, by and among CĪON Investment Corporation and certain institutional investors.
99.1	Press Release dated December 18, 2025.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

Section	Heading	Page

Section 1.	Authorization of Notes; Interest Rate	1

Section 1.1.	Authorization of Notes	1
Section 1.2.	Changes in Interest Rate	1

Section 2.	Sale and Purchase of Notes	2

Section 3.	Closing	3

Section 4.	Conditions to Closing	3

Section 4.1.	Representations and Warranties	3
Section 4.2.	Performance; No Default	3
Section 4.3.	Compliance Certificates	3
Section 4.4.	Opinions of Counsel	4
Section 4.5.	Purchase Permitted By Applicable Law, Etc.	4
Section 4.6.	Sale of Other Notes	4
Section 4.7.	Payment of Special Counsel Fees	4
Section 4.8.	CUSIP Number	4
Section 4.9.	Changes in Corporate Structure	5
Section 4.10.	Funding Instructions	5
Section 4.11.	Rating	5
Section 4.12.	Consent of Holders of Other Indebtedness	5
Section 4.13.	Note Listing	5
Section 4.14.	Proceedings and Documents	5

Section 5.	Representations and Warranties of the Company	6

Section 5.1.	Organization; Power and Authority	6
Section 5.2.	Authorization, Etc.	6
Section 5.3.	Disclosure	6
Section 5.4.	Organization and Ownership of Shares of Subsidiaries; Affiliates	7
Section 5.5.	Financial Statements; Material Liabilities	7
Section 5.6.	Compliance with Laws, Other Instruments, Etc.	8
Section 5.7.	Governmental Authorizations, Etc.	8
Section 5.8.	Litigation; Observance of Agreements, Statutes and Orders	8
Section 5.9.	Taxes	8
Section 5.10.	Portfolio Assets	9
Section 5.11.	Licenses, Permits, Etc.	9
Section 5.12.	Employee Matters; Certain ERISA Matters	9
Section 5.13.	Private Offering by the Company	10
Section 5.14.	Use of Proceeds; Margin Regulations	10

Section 5.15.	Existing Indebtedness; Future Liens	10
Section 5.16.	Foreign Assets Control Regulations, Etc.	11
Section 5.17.	Status under Certain Statutes	12
Section 5.18.	Environmental Matters	12
Section 5.19.	Investment Company Act	12

Section 6.	Representations of the Purchasers	13

Section 6.1.	Purchase for Investment	13
Section 6.2.	Source of Funds	13
Section 6.3.	Placement Agents	15
Section 6.4.	Information	15
Section 6.5.	No Representations	15

Section 7.	Information as to the Company	16

Section 7.1.	Financial and Business Information	16
Section 7.2.	Officer’s Certificate	17
Section 7.3.	Visitation	18
Section 7.4.	Electronic Delivery	19

Section 8.	Payment and Prepayment of the Notes	19

Section 8.1.	Maturity	19
Section 8.2.	Optional Prepayments with Prepayment Settlement Amount	20
Section 8.3.	Allocation of Partial Prepayments	20
Section 8.4.	Maturity; Surrender, Etc.	20
Section 8.5.	Purchase of Notes	21
Section 8.6.	Make-Whole Amount; Prepayment Settlement Amount	21
Section 8.7.	Payments Due on Non-Business Days	23
Section 8.8.	Change in Control	23

Section 9.	Affirmative Covenants.	24

Section 9.1.	Compliance with Laws	24
Section 9.2.	Insurance	25
Section 9.3.	Maintenance of Properties	25
Section 9.4.	Payment of Taxes and Claims	25
Section 9.5.	Corporate Existence, Etc.	25
Section 9.6.	Books and Records	25
Section 9.7.	Subsidiary Guarantors	26
Section 9.8.	Status of RIC and BDC	27
Section 9.9.	Investment Policies	27
Section 9.10.	Rating Confirmation	27
Section 9.11.	Priority of Obligations	27

	100 Park Avenue, 25th Floor New York, New York 10017
	(Address of Principal Executive Offices)

	(212) 418-4700
	(Registrant’s telephone number, including area code)

	Not applicable
	(Former name or former address, if changed since last report)


Section 10.	Negative Covenants.	28

Section 10.1.	Transactions with Affiliates	28
Section 10.2.	Merger, Consolidation, Etc.	28
Section 10.3.	Line of Business	29
Section 10.4.	Economic Sanctions, Etc.	30
Section 10.5.	Liens	30
Section 10.6.	Financial Covenants	30
Section 10.7.	Most Favored Lender.	31
Section 10.8.	Distributions, Repurchases and Redemptions	32

Section 11.	Events of Default	32

Section 12.	Remedies on Default, Etc.	34

Section 12.1.	Acceleration	34
Section 12.2.	Other Remedies	35
Section 12.3.	Rescission of Declaration	35
Section 12.4.	No Waivers or Election of Remedies, Expenses, Etc.	36

Section 13.	The Notes; Registration; Exchange; Substitution of Notes	36

Section 13.1.	Form and Dating	36
Section 13.2.	Execution and Authentication	37
Section 13.3.	Registrar and Paying Agent	37
Section 13.4.	Transfer and Exchange of Global Notes	38
Section 13.5.	Transfer and Exchange of Certificated Notes	38
Section 13.6.	Replacement of Notes	39
Section 13.7.	Transfer and Exchange of Interests in Global Notes	49
Section 13.8.	Notes Legends	40

Section 14.	Payments on Notes	42

Section 14.1.	Place of Payment	42
Section 14.2.	Payment by Wire Transfer	43
Section 14.3.	FATCA Information	43

Section 15.	Expenses, Etc.	44

Section 15.1.	Transaction Expenses	44
Section 15.2.	Certain Taxes	44
Section 15.3.	Survival	45

Section 16.	Survival of Representations and Warranties; Entire Agreement	45

Section 17.	Amendment and Waiver	45

Section 17.1.	Requirements	45
Section 17.2.	Solicitation of Holders of Notes	46
Section 17.3.	Binding Effect, Etc.	46
Section 17.4.	Notes Held by Company, Etc.	46

Section 18.	Notices	47

Section 19.	Reproduction of Documents	48

Section 20.	Confidential Information	48

Section 21.	Substitution of Purchaser	49

Section 22.	Miscellaneous	50

Section 22.1.	Successors and Assigns	50
Section 22.2.	Accounting Terms	50
Section 22.3.	Severability	50
Section 22.4.	Construction, Etc.	50
Section 22.5.	Counterparts; Electronic Contracting	51
Section 22.6.	Governing Law	51
Section 22.7.	Jurisdiction and Process; Waiver of Jury Trial	52

Signature		53

Schedule A	—	Defined Terms

Schedule 1-A	—	Form of 7.41% Senior Unsecured Note due December 15, 2027

Schedule 1-B	—	Form of 7.70% Senior Unsecured Note due December 15, 2029

Schedule 5.3	—	Disclosure Materials

Schedule 5.4	—	Subsidiaries of the Company and Ownership of Subsidiary Stock

Schedule 5.5	—	Financial Statements

Schedule 5.15	—	Existing Indebtedness

Purchaser Schedule	—	Information Relating to Purchasers

Prepaid or accelerated during the period		Prepayment Settlement Amount
On or before September 14, 2027		Make-Whole Amount
After September 14, 2027		Zero.

Prepaid or accelerated during the period		Prepayment Settlement Amount
On or before September 14, 2029		Make-Whole Amount
After September 14, 2029		Zero.

	Very truly yours,

	CĪON Investment Corporation


	By:	/s/ Michael A. Reisner
		Name: Michael A. Reisner
		Title: Co-Chief Executive Officer

	U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Authenticating Agent


	By
		Name:
		Title: Authorized Signatory

Date of increase or decrease	Amount of decrease in principal amount of this Global Note	Amount of increase in principal amount of this Global Note	Principal amount of this Global Note following such decrease or increase	Signature of authorized officer of Registrar